Overview

Dose Response Study of a Topical Gel for the Treatment of Raynaud's Phenomenon

Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The Purpose of this study is to determine the response to two different strengths of a topical gel containing nitroglycerin in patients with Raynaud's disease.
Phase:
Phase 2
Details
Lead Sponsor:
MediQuest Therapeutics
Treatments:
Nitroglycerin